mRNA: F

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

HSD17B13 VARIANTS AND USES THEREOF
EP 3571301 A1申请人: REGENERON PHARMA优先权: 2017
CN
EP
US
WO
10 件公开
ENGINEERED NIPAH VIRUS MRNA VACCINE
EP 4661904 A2申请人: VERNAGEN LLC优先权: 2023
CN
EP
US
WO
4 件公开
RSV VACCINE
EP 4746905 A1申请人: ASTRAZENECA AB优先权: 2023
CN
EP
US
WO
4 件公开
RESPIRATORY SYNCYTIAL VIRUS MRNA VACCINE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
EP 4678741 A1申请人: HANGZHOU TIANLONG PHARMACEUTICAL CO LTD优先权: 2024
CN
EP
US
4 件公开
Methods for reducing protein levels in a cell
US 9597346 B2申请人: ZHOU PENGBO优先权: 2010
CN
US
4 件公开
Nucleic Acid-Lipid Nanoparticle Suitable for Intramuscular Administration, Preparation Thereof, and Use Thereof
US 20260199450 A1申请人: CHENGDU NUOEN GENOMICS LTD优先权: 2022
CN
US
WO
3 件公开
NOVEL HUMAN SYNCYTIAL VIRUS RSV B MRNA VACCINE
WO 2025214210 A1申请人: NEXTRANSLATE BIOPHARMACEUTICAL HANGZHOU CO LTD优先权: 2024
CN
WO
3 件公开
Respiratory syncytial virus mRNA vaccine
- US 12239701 B2
  申请人: VERNAGEN LLC优先权: 2023
  CN
  US
  2 件公开
- CN 121378427 A
  申请人: UNIV SOUTH CHINA TECH优先权: 2025
  CN
MUTANT OF RSV PRE-FUSION CONFORMATIONAL F PROTEIN AND USE THEREOF
WO 2025031378 A1申请人: BEIJING NEOCURNA BIOTECHNOLOGY CORP优先权: 2023
CN
WO
2 件公开
MRNA VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS
WO 2025093011 A1申请人: NANORIBO SHANGHAI BIOTECHNOLOGY CO LTD优先权: 2023
CN
WO
2 件公开